Some researchers also observed the important role of peripheral blood CD4+ T cells in predicting the OS and chemotherapy effect of patients with pancreatic cancer, and they hypothesize that the CD4+ T cell compartment may have a critical role in response to chemoimmunotherapy treatment in metastatic pancreatic ductal adenocarcinoma.13 The gene discussed is CD4; the disease is pancreatic ductal adenocarcinoma.